\Sexpr{set_parent("supplementary_SIM-Rev1_v0.Rnw")}


<<echo=FALSE>>=
opts_chunk$set (warning = FALSE, message = FALSE, tidy=TRUE, echo=FALSE, dev = 'pdf')
options(warn=-1)
@

<<echo=FALSE>>=
rm(list=ls())
# For KM plots
codepath<-c("../../R/")
source(paste0(codepath,"source_forestsearch_v0.R"))
source_fs_functions(file_loc=codepath)
library(survival)
@


<<echo=FALSE,eval=TRUE>>=
# supplementary "validation"
gbsg_validate <-within(rotterdam,{
rfstime <- ifelse(recur==1,rtime,dtime)
#rfstime <- pmin(rtime,dtime)
t_months<-rfstime/30.4375
time_months <- t_months
status <- pmax(recur,death)
# censor if beyond 84 months ?
#time_months <- pmin(t_months,84)
#status <- ifelse(status==1 & t_months <= 84,1,0)
# Second version (conservative per Therneau)
ignore <- (recur==0 & death==1 & rtime < dtime)
status2 <- ifelse(recur==1 | ignore, recur, death)
rfstime2 <- ifelse(recur==1 | ignore, rtime,dtime)
time_months2 <- rfstime2/30.4375
grade3 <- ifelse(grade=="3",1,0)
treat <- hormon
id<-as.numeric(c(1:nrow(rotterdam)))  
SG0 <- ifelse(er<=0,0,1)
wt_one <- 1
})
# Check subject 40 who was censored at recurrence but death afterwards
# Event at 6.6 years
#subset(gbsg_validate,pid==40)

tte.name<-c("time_months")
event.name<-c("status")
treat.name<-c("treat")
wt.name <- c("sw.weights")

# node positive to match gbsg?
df.analysis <- subset(gbsg_validate, nodes > 0)
@

<<echo=FALSE,eval=FALSE>>=

pdf(file = "plot_KM_gbsg-validate.pdf",   
width = 10, height = 10) 

par(mfrow=c(1,2))

# risk set
byrisk <- 18
risk.cex<-0.70
legend.cex<-0.90

fit.ps <- glm(treat ~ age+meno+size+grade3+nodes+pgr+chemo+er, data=df.analysis, family="binomial")
pihat <- fit.ps$fitted
pihat.null <- glm(treat ~ 1, family="binomial", data=df.analysis)$fitted
wt.1 <- pihat.null/pihat
wt.0 <- (1-pihat.null)/(1-pihat)
# Stabilized weight
df.analysis$sw.weights <- ifelse(df.analysis$treat==1, wt.1,wt.0)


# Add all events
evs<-sort(unique(df.analysis$time_months[which(df.analysis$status==1)]))
tpoints.add<-c(-1,evs,max(df.analysis$time_months))

dfp <- subset(df.analysis, er<=0)

kmH.fit<-KM.plot.2sample.weighted(Y=dfp[,c(tte.name)],E=dfp[,c(event.name)],Treat=dfp[,c(treat.name)],
                                  Weight=dfp[,c(wt.name)],
                                  risk.set=TRUE,by.risk=byrisk,tpoints.add=tpoints.add,risk.cex=risk.cex,
                                  stop.onerror=TRUE,check.KM=TRUE,
                                  Xlab="Months",Ylab="Recurrence-free Survival",details=FALSE,
                                  show.ticks=TRUE,
                                  col.1="black", col.2="blue",
                                  ltys=c(1,2),lwds=c(3,3),
                                  plotit=TRUE, risk_offset=0.125, risk_delta=0.05,
                                  show.logrank=FALSE,show.med=FALSE,show.cox=TRUE)
title(sub="(a) Estrogen = 0")


dfp <- subset(df.analysis, er>0)

kmH.fit<-KM.plot.2sample.weighted(Y=dfp[,c(tte.name)],E=dfp[,c(event.name)],Treat=dfp[,c(treat.name)],
                                  Weight=dfp[,c(wt.name)],
                                  risk.set=TRUE,by.risk=byrisk,tpoints.add=tpoints.add,risk.cex=risk.cex,
                                  show.Y.axis=FALSE,
                                  stop.onerror=TRUE, check.KM=TRUE,
                                  Xlab="Months",Ylab="",details=FALSE,
                                  show.ticks=TRUE,
                                  col.1="black", col.2="blue",
                                  ltys=c(1,2),lwds=c(3,3), 
                                  plotit=TRUE, risk_offset=0.125, risk_delta=0.05,
                                  show.logrank=FALSE,show.med=FALSE,show.cox=TRUE)
title(sub="(b) Estrogen > 0")

dev.off()

@


\begin{figure}
\begin{center}
\includegraphics[width=\textwidth, height=3.25in]{plot_KM_gbsg-validate.pdf}
\end{center}
\caption{Application of GBSG subgroups to Rotterdam tumor bank data}
\label{fig:gbsg_validate}
\end{figure}

We apply the subgroup definitions based on the GBSG analysis to the Rotterdam data \citep{Foekens_2000} which was utilized for ``external validation of a Cox prognostic model'' \citep{Royston_2013}.  Because the Rotterdam data is purely observational we use (stabilized) propensity-score weighting as described by \citealp{Cole_2004}.  Recall, from the GBSG data analysis, subjects without estrogen receptors are anticipated to not benefit from treatment whereas subjects with positive estrogen are anticipated to benefit:  The bias corrected hazard ratio estimates were $1.58$ $(0.86, 2.9)$ and $0.64$ $(0.44, 0.93)$.  Though a trend suggesting detriment for subjects without estrogen levels, the $95\%$ CI did not support statistical significance.   Figure \ref{fig:gbsg_validate} displays the (stabilized propensity-score weighted) Kaplan-Meier curves along with the corresponding weighted Cox model estimates.   The Cox model estimates were $0.55$ $(0.30, 1.01)$ and $0.65$ $(0.49, 0.86)$, respectively.  Here we see that, in contrast to that forecasted via the GBSG results, subjects without estrogen levels trended towards a favorable benefit (Note that there are only 36 [stabilized weighted sum] 
subjects in the treated arm).  Whereas estimates for subjects with positive estrogen levels are fairly consistent with the GBSG forecast.    



